1. Define HIV The Human Immunodeficiency Virus (HIV) is a virus that attacks the body's immune system, specifically the CD4 T cells, which are crucial for fighting off infections. Over time, it weakens the immune system, leading to Acquired Immunodeficiency Syndrome (AIDS)*, a severe stage where the body becomes highly vulnerable to opportunistic infections and certain cancers. 2. Predisposing factors Unprotected sexual intercourse (vaginal, anal, oral) Having multiple sexual partners Presence of other sexually transmitted infections (STIs) Sharing contaminated needles or syringes (e.g., for drug use) Mother-to-child transmission (during pregnancy, childbirth, or breastfeeding) 3. 5 mode of transmission Sexual transmission: Through unprotected sexual contact with an infected person. Blood-to-blood transmission: Sharing contaminated needles, transfusions of infected blood (rare now due to screening), or accidental needle-stick injuries. Mother-to-child transmission (MTCT): From an HIV-positive mother to her child during pregnancy, childbirth, or breastfeeding. Organ/tissue transplantation: Receiving an organ or tissue from an HIV-positive donor (also rare due to screening). Occupational exposure: Healthcare workers exposed to infected blood or body fluids through cuts or needle sticks. 4. Life cycle Binding and Fusion: HIV attaches to CD4 receptors and co-receptors on the host cell, then fuses with the cell membrane. Reverse Transcription: The viral RNA is converted into viral DNA by the enzyme reverse transcriptase*. Integration: The viral DNA enters the cell's nucleus and integrates into the host cell's DNA. Replication: The integrated viral DNA uses the host cell's machinery to produce new viral RNA and proteins. Assembly and Budding: New viral components assemble into new HIV particles, which then bud off from the host cell, ready to infect other cells. 5. Progression staging according to WHO Stage 1 (Asymptomatic): No symptoms, or persistent generalized lymphadenopathy*. Stage 2 (Mild Symptoms): Minor mucocutaneous manifestations, recurrent upper respiratory tract infections. Stage 3 (Advanced Symptoms): Unexplained chronic diarrhea, severe bacterial infections, pulmonary tuberculosis, unexplained anemia. Stage 4 (Severe Symptoms/AIDS): HIV wasting syndrome, Pneumocystis pneumonia (PCP), Kaposi's sarcoma*, toxoplasmosis of the brain, cryptococcal meningitis. 6. Sign and symptoms according to stages Stage 1: Often asymptomatic, but persistent generalized lymphadenopathy* (swollen lymph nodes) may be present. Stage 2: Herpes zoster (shingles), recurrent oral ulcers, papular pruritic eruptions, fungal nail infections*. Stage 3: Unexplained chronic diarrhea (lasting >1 month), severe bacterial infections (e.g., pneumonia, pyomyositis), pulmonary tuberculosis, oral hairy leukoplakia, unexplained anemia*. Stage 4: HIV wasting syndrome (unexplained weight loss >10% of body weight), Pneumocystis pneumonia (PCP), Kaposi's sarcoma, toxoplasmosis of the brain, cryptococcal meningitis, extrapulmonary tuberculosis*. 7. Management (history, physical examination, laboratory investigation according to Zambian) History: Detailed sexual history, history of drug use, previous STIs, current symptoms, family history of HIV/TB. Physical Examination: General appearance, assessment of lymph nodes, skin, oral cavity, respiratory, gastrointestinal, and neurological systems. Laboratory Investigation (Zambia): HIV rapid diagnostic tests (RDTs) for screening, followed by confirmatory tests. CD4 count (though less critical for ART initiation due to "Test and Treat"). Viral load monitoring (to assess treatment effectiveness). Full blood count, liver and kidney function tests* (to monitor drug side effects and overall health). TB screening (e.g., GeneXpert, sputum smear). STI screening (e.g., syphilis, gonorrhea). Hepatitis B and C screening. 8. Treatment (in Zambia) Zambia provides Antiretroviral Therapy (ART)* free of charge to all diagnosed individuals. The country follows a "Test and Treat" policy, meaning anyone diagnosed with HIV is immediately eligible for ART, regardless of their CD4 count or clinical stage. Common first-line regimens include combinations of drugs like Tenofovir, Lamivudine, and Dolutegravir (TLD). Emphasis is placed on adherence to medication and regular viral load monitoring* to ensure treatment effectiveness and achieve viral suppression. 9. Pillars (of HIV response) Prevention: Comprehensive sexuality education, condom promotion, Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP)*, voluntary medical male circumcision (VMMC), harm reduction for people who inject drugs. Testing and Diagnosis: Widespread access to HIV testing services. Treatment: Universal access to Antiretroviral Therapy (ART)*. Care and Support: Psychosocial support, nutrition, management of opportunistic infections. Elimination of Mother-to-Child Transmission (EMTCT). 10. 90 90 90 treatment strategy This is a UNAIDS target aiming to end the AIDS epidemic by 2030. It seeks to achieve: 90% of all people living with HIV know their HIV status. 90% of all people with diagnosed HIV infection receive sustained antiretroviral therapy. 90% of all people receiving antiretroviral therapy achieve viral suppression. 11. HIV work policy An HIV work policy is a framework designed to protect the rights of employees living with HIV, prevent discrimination, ensure confidentiality, and promote a safe and supportive work environment. Key aspects include non-discrimination, confidentiality, reasonable accommodation for employees living with HIV, education and awareness programs, and provisions for access to information and services*. Send me the next one 📸